Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

China Launches Dual-Track Reimbursement System for Innovative Drugs to Boost Global Pharma Access

Monday, February 23, 2026

China has introduced a dualtrack reimbursement system for innovative drugs creating new pathways for global pharmaceutical manufacturers to enter the market more efficiently

Teva and Medincell Receives FDA Acceptance for Once-Monthly Olanzapine Injection for Schizophrenia

Saturday, February 21, 2026

Teva Pharmaceutical Industries and Medincell have announced that the US Food and Drug Administration has accepted their New Drug Application NDA for TEV an investigational olanzapine extendedrelease injectable suspension

AstraZeneca’s CALQUENCE plus Venetoclax Approved in the US as First All-Oral Fixed-Duration Regimen for First-Line CLL

Saturday, February 21, 2026

AstraZeneca has received approval from the US Food and Drug Administration for CALQUENCE acalabrutinib in combination with venetoclax as a firstline treatment for adults with chronic lymphocytic leukaemia CLL and small lymphocytic lymphoma SLL

VivaMed BioPharma Enters into Partnership with Syngene International to Strengthen AI-driven Drug Repurposing Programmes

Friday, February 20, 2026

VivaMed BioPharma has entered into a strategic partnership with Syngene International to support the development and validation of therapeutic programmes identified through artificial intelligence AI

Catalent and S.Biomedics Partner to Advance Development and Manufacturing of TED-A9

Thursday, February 19, 2026

Catalent and SBiomedics have announced a strategic partnership to support the development and manufacture of TEDA an allogeneic pluripotent stem cellderived dopaminergic precursor cell therapy

Unnatural Products Enters into Collaboration with Novartis for Macrocyclic Peptide Therapeutics

Thursday, February 19, 2026

Unnatural Products has announced a research collaboration and licensing agreement with Novartis to advance the development of macrocyclic peptide therapeutics under an undisclosed programme

Merck Enters into Collaboration with Mayo Clinic to Advance AI-Enabled Drug Discovery

Thursday, February 19, 2026

Merck has entered into a research and development agreement with Mayo Clinic to support AIenabled drug discovery and precision medicine initiatives

Akeso Inc Secures NMPA Approval for Novel Bispecific Antibody Targeting Alzheimer's in China

Wednesday, February 18, 2026

Akeso Incs innovative bispecific antibody targeting amyloidbeta and BBB receptor receives approval from Chinas NMPA accelerating biopharma innovation in Asia

Scribe Therapeutics Enters into Collaboration with Lilly for In Vivo CRISPR-Based Genetic Medicines

Wednesday, February 18, 2026

Scribe Therapeutics has achieved a second success milestone under its collaboration with Eli Lilly and Company marking further progress in the development of in vivo CRISPRbased genetic medicines

JAX-NYSCF and GSK Partner to Advance Translational Models for Neurodegenerative Diseases

Wednesday, February 18, 2026

The Jackson LaboratoryNew York Stem Cell Foundation Collaborative JAXNYSCF has entered into a fiveyear strategic research collaboration with GSK to advance human cellular models for neurodegenerative diseases including Alzheimers disease